| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 1.92e-08 | 582 | 25 | 9 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.68e-08 | 417 | 25 | 8 | GO:0061629 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.75e-07 | 753 | 25 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.58e-07 | 560 | 25 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.80e-07 | 566 | 25 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | NR4A2 PLAGL1 REL NEUROD1 RUNX1 MED1 KDM6B NOTCH2 SMAD1 ARNT2 | 1.43e-06 | 1271 | 25 | 10 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4.97e-06 | 1459 | 25 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.13e-05 | 1244 | 25 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.36e-05 | 55 | 25 | 3 | GO:0042974 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.08e-05 | 187 | 25 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 1.79e-04 | 16 | 25 | 2 | GO:0023029 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 2.23e-04 | 1412 | 25 | 8 | GO:0000981 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.27e-04 | 18 | 25 | 2 | GO:0042809 | |
| GeneOntologyMolecularFunction | chromatin binding | 2.44e-04 | 739 | 25 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 2.54e-04 | 19 | 25 | 2 | GO:0032394 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.11e-04 | 21 | 25 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.75e-04 | 23 | 25 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone acetyltransferase binding | 5.98e-04 | 29 | 25 | 2 | GO:0035035 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.24e-04 | 34 | 25 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.41e-03 | 398 | 25 | 4 | GO:0046982 | |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.99e-03 | 53 | 25 | 2 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 2.07e-03 | 54 | 25 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | MHC protein binding | 2.38e-03 | 58 | 25 | 2 | GO:0042287 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 2.63e-03 | 61 | 25 | 2 | GO:0030374 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 4.81e-03 | 83 | 25 | 2 | GO:1990841 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.91e-03 | 562 | 25 | 4 | GO:0003712 | |
| GeneOntologyMolecularFunction | SMAD binding | 5.16e-03 | 86 | 25 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 5.61e-03 | 1356 | 25 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.21e-03 | 303 | 25 | 3 | GO:0003713 | |
| GeneOntologyMolecularFunction | microtubule binding | 6.50e-03 | 308 | 25 | 3 | GO:0008017 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 9.82e-03 | 120 | 25 | 2 | GO:0008013 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 1.32e-02 | 140 | 25 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | histone deacetylase binding | 1.45e-02 | 147 | 25 | 2 | GO:0042826 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 1.53e-02 | 1205 | 25 | 5 | GO:0046983 | |
| GeneOntologyMolecularFunction | tubulin binding | 1.59e-02 | 428 | 25 | 3 | GO:0015631 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.62e-02 | 156 | 25 | 2 | GO:0019838 | |
| GeneOntologyMolecularFunction | immune receptor activity | 1.80e-02 | 165 | 25 | 2 | GO:0140375 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.84e-02 | 167 | 25 | 2 | GO:0031490 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NR4A2 MED14 PLAGL1 REL MYOCD NEUROD1 RUNX1 MED1 KDM6B NOTCH2 SMAD1 ARNT2 | 1.91e-08 | 1390 | 25 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 2.08e-06 | 327 | 25 | 6 | GO:0048738 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 2.89e-06 | 83 | 25 | 4 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 3.03e-06 | 84 | 25 | 4 | GO:0061614 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 3.03e-06 | 349 | 25 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 3.21e-06 | 558 | 25 | 7 | GO:0060537 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 4.29e-06 | 1141 | 25 | 9 | GO:0045597 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 4.66e-06 | 850 | 25 | 8 | GO:0071363 | |
| GeneOntologyBiologicalProcess | brain development | 5.04e-06 | 859 | 25 | 8 | GO:0007420 | |
| GeneOntologyBiologicalProcess | response to growth factor | 6.17e-06 | 883 | 25 | 8 | GO:0070848 | |
| GeneOntologyBiologicalProcess | central nervous system development | 6.35e-06 | 1197 | 25 | 9 | GO:0007417 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 6.84e-06 | 103 | 25 | 4 | GO:2000628 | |
| GeneOntologyBiologicalProcess | head development | 8.28e-06 | 919 | 25 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 1.21e-05 | 119 | 25 | 4 | GO:0010586 | |
| GeneOntologyBiologicalProcess | epithelium development | 3.30e-05 | 1469 | 25 | 9 | GO:0060429 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 4.65e-05 | 338 | 25 | 5 | GO:0045165 | |
| GeneOntologyBiologicalProcess | response to insecticide | 5.05e-05 | 9 | 25 | 2 | GO:0017085 | |
| GeneOntologyBiologicalProcess | thyroid hormone receptor signaling pathway | 5.05e-05 | 9 | 25 | 2 | GO:0002154 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 5.40e-05 | 61 | 25 | 3 | GO:1902895 | |
| GeneOntologyBiologicalProcess | developmental growth | 7.65e-05 | 911 | 25 | 7 | GO:0048589 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 9.25e-05 | 73 | 25 | 3 | GO:2000630 | |
| GeneOntologyBiologicalProcess | diencephalon development | 1.72e-04 | 90 | 25 | 3 | GO:0021536 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.89e-04 | 1053 | 25 | 7 | GO:0000122 | |
| GeneOntologyBiologicalProcess | embryo development | 2.01e-04 | 1437 | 25 | 8 | GO:0009790 | |
| GeneOntologyBiologicalProcess | organelle transport along microtubule | 2.15e-04 | 97 | 25 | 3 | GO:0072384 | |
| GeneOntologyBiologicalProcess | heart development | 2.33e-04 | 757 | 25 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | forebrain development | 2.63e-04 | 489 | 25 | 5 | GO:0030900 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 3.79e-04 | 289 | 25 | 4 | GO:0009636 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 3.83e-04 | 24 | 25 | 2 | GO:0008090 | |
| GeneOntologyBiologicalProcess | muscle structure development | 4.57e-04 | 858 | 25 | 6 | GO:0061061 | |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 4.86e-04 | 27 | 25 | 2 | GO:0060216 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 4.92e-04 | 870 | 25 | 6 | GO:0030855 | |
| GeneOntologyBiologicalProcess | growth | 5.02e-04 | 1235 | 25 | 7 | GO:0040007 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 5.23e-04 | 28 | 25 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | positive regulation of myeloid cell differentiation | 5.55e-04 | 134 | 25 | 3 | GO:0045639 | |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization, microtubule-mediated | 6.01e-04 | 30 | 25 | 2 | GO:0034643 | |
| GeneOntologyBiologicalProcess | mitochondrion transport along microtubule | 6.01e-04 | 30 | 25 | 2 | GO:0047497 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 6.05e-04 | 138 | 25 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | limbic system development | 6.44e-04 | 141 | 25 | 3 | GO:0021761 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 6.51e-04 | 596 | 25 | 5 | GO:0001701 | |
| GeneOntologyBiologicalProcess | embryonic hemopoiesis | 6.84e-04 | 32 | 25 | 2 | GO:0035162 | |
| GeneOntologyBiologicalProcess | heart growth | 7.42e-04 | 148 | 25 | 3 | GO:0060419 | |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 8.19e-04 | 35 | 25 | 2 | GO:0048333 | |
| GeneOntologyBiologicalProcess | axon development | 9.11e-04 | 642 | 25 | 5 | GO:0061564 | |
| GeneOntologyBiologicalProcess | establishment of mitochondrion localization | 1.02e-03 | 39 | 25 | 2 | GO:0051654 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | 1.06e-03 | 1399 | 25 | 7 | GO:0045892 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 1.07e-03 | 40 | 25 | 2 | GO:0003161 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | 1.12e-03 | 1413 | 25 | 7 | GO:1902679 | |
| GeneOntologyBiologicalProcess | neuron development | 1.37e-03 | 1463 | 25 | 7 | GO:0048666 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.41e-03 | 46 | 25 | 2 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.41e-03 | 46 | 25 | 2 | GO:0072574 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 1.43e-03 | 186 | 25 | 3 | GO:0006367 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.45e-03 | 713 | 25 | 5 | GO:0048598 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.60e-03 | 49 | 25 | 2 | GO:0072576 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 1.69e-03 | 197 | 25 | 3 | GO:0010970 | |
| GeneOntologyBiologicalProcess | vesicle transport along microtubule | 1.73e-03 | 51 | 25 | 2 | GO:0047496 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 1.74e-03 | 199 | 25 | 3 | GO:0051147 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA binding | 1.80e-03 | 52 | 25 | 2 | GO:0043388 | |
| GeneOntologyBiologicalProcess | liver development | 1.82e-03 | 202 | 25 | 3 | GO:0001889 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.82e-03 | 750 | 25 | 5 | GO:0048729 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 1.89e-03 | 205 | 25 | 3 | GO:0061008 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 1.94e-03 | 54 | 25 | 2 | GO:0032968 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 1.94e-03 | 54 | 25 | 2 | GO:0051150 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.95e-03 | 1133 | 25 | 6 | GO:0043066 | |
| GeneOntologyBiologicalProcess | hindbrain development | 1.97e-03 | 208 | 25 | 3 | GO:0030902 | |
| GeneOntologyBiologicalProcess | anterograde axonal transport | 2.01e-03 | 55 | 25 | 2 | GO:0008089 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 2.08e-03 | 212 | 25 | 3 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of keratinocyte proliferation | 2.09e-03 | 56 | 25 | 2 | GO:0010837 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 2.30e-03 | 1171 | 25 | 6 | GO:0043069 | |
| GeneOntologyBiologicalProcess | cellular defense response | 2.39e-03 | 60 | 25 | 2 | GO:0006968 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 2.47e-03 | 225 | 25 | 3 | GO:0030705 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 2.50e-03 | 1190 | 25 | 6 | GO:0008284 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 2.55e-03 | 62 | 25 | 2 | GO:0032786 | |
| GeneOntologyBiologicalProcess | mitochondrion localization | 2.63e-03 | 63 | 25 | 2 | GO:0051646 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.64e-03 | 817 | 25 | 5 | GO:0048514 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.66e-03 | 231 | 25 | 3 | GO:0006352 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.37e-08 | 596 | 26 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 8.50e-07 | 272 | 26 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 2.55e-05 | 1377 | 26 | 9 | GO:0140513 | |
| GeneOntologyCellularComponent | chromatin | 4.52e-05 | 1480 | 26 | 9 | GO:0000785 | |
| GeneOntologyCellularComponent | core mediator complex | 4.75e-04 | 26 | 26 | 2 | GO:0070847 | |
| GeneOntologyCellularComponent | apical dendrite | 7.21e-04 | 32 | 26 | 2 | GO:0097440 | |
| GeneOntologyCellularComponent | mediator complex | 9.65e-04 | 37 | 26 | 2 | GO:0016592 | |
| GeneOntologyCellularComponent | postsynaptic cytosol | 1.43e-03 | 45 | 26 | 2 | GO:0099524 | |
| GeneOntologyCellularComponent | early endosome membrane | 2.25e-03 | 212 | 26 | 3 | GO:0031901 | |
| GeneOntologyCellularComponent | early endosome | 2.77e-03 | 481 | 26 | 4 | GO:0005769 | |
| GeneOntologyCellularComponent | axon cytoplasm | 3.22e-03 | 68 | 26 | 2 | GO:1904115 | |
| GeneOntologyCellularComponent | dendritic spine | 3.27e-03 | 242 | 26 | 3 | GO:0043197 | |
| GeneOntologyCellularComponent | growth cone | 3.39e-03 | 245 | 26 | 3 | GO:0030426 | |
| GeneOntologyCellularComponent | cytosolic region | 3.41e-03 | 70 | 26 | 2 | GO:0099522 | |
| GeneOntologyCellularComponent | neuron spine | 3.47e-03 | 247 | 26 | 3 | GO:0044309 | |
| GeneOntologyCellularComponent | site of polarized growth | 3.71e-03 | 253 | 26 | 3 | GO:0030427 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | NR4A2 FNDC3B NCOR1 MYOCD KIF5A NEUROD1 RUNX1 KDM6B MAP1B CEP57 HAP1 NOTCH2 ARNT2 | 1.29e-08 | 1269 | 23 | 13 | MP:0011111 |
| MousePheno | perinatal lethality | NR4A2 FNDC3B PLAGL1 KIF5A NEUROD1 RUNX1 KDM6B MAP1B CEP57 NOTCH2 ARNT2 | 5.00e-07 | 1130 | 23 | 11 | MP:0002081 |
| MousePheno | neonatal lethality | 2.46e-06 | 799 | 23 | 9 | MP:0002058 | |
| MousePheno | abnormal fluid regulation | 3.24e-06 | 826 | 23 | 9 | MP:0001784 | |
| MousePheno | dehydration | 9.39e-06 | 83 | 23 | 4 | MP:0001429 | |
| MousePheno | perinatal lethality, complete penetrance | 1.08e-05 | 712 | 23 | 8 | MP:0011089 | |
| MousePheno | abnormal pericardium morphology | 2.74e-05 | 225 | 23 | 5 | MP:0000288 | |
| MousePheno | postnatal lethality | 2.96e-05 | 1084 | 23 | 9 | MP:0002082 | |
| MousePheno | pericardial effusion | 2.97e-05 | 111 | 23 | 4 | MP:0005312 | |
| MousePheno | abnormal paraventricular hypothalamic nucleus morphology | 5.41e-05 | 7 | 23 | 2 | MP:0008845 | |
| MousePheno | increased nucleated erythrocyte cell number | 6.02e-05 | 47 | 23 | 3 | MP:0009395 | |
| MousePheno | abnormal nucleated erythrocyte cell number | 6.82e-05 | 49 | 23 | 3 | MP:0012397 | |
| MousePheno | effusion | 1.01e-04 | 152 | 23 | 4 | MP:0021205 | |
| MousePheno | abnormal lung morphology | 1.65e-04 | 767 | 23 | 7 | MP:0001175 | |
| MousePheno | neonatal lethality, complete penetrance | 1.75e-04 | 534 | 23 | 6 | MP:0011087 | |
| MousePheno | abnormal hypothalamic nucleus morphology | 2.00e-04 | 13 | 23 | 2 | MP:0020872 | |
| MousePheno | abnormal third ventricle morphology | 2.73e-04 | 78 | 23 | 3 | MP:0000826 | |
| MousePheno | abnormal bone ossification | 3.88e-04 | 395 | 23 | 5 | MP:0008271 | |
| MousePheno | decreased circulating triiodothyronine level | 3.90e-04 | 18 | 23 | 2 | MP:0005479 | |
| MousePheno | decreased activity of thyroid gland | 5.34e-04 | 21 | 23 | 2 | MP:0003503 | |
| MousePheno | decreased triiodothyronine level | 6.42e-04 | 23 | 23 | 2 | MP:0005473 | |
| MousePheno | postnatal lethality, complete penetrance | 6.69e-04 | 445 | 23 | 5 | MP:0011085 | |
| MousePheno | enlarged third ventricle | 8.86e-04 | 27 | 23 | 2 | MP:0008536 | |
| MousePheno | abnormal circulating triiodothyronine level | 9.54e-04 | 28 | 23 | 2 | MP:0005476 | |
| MousePheno | abnormal respiratory system morphology | 9.75e-04 | 1027 | 23 | 7 | MP:0002132 | |
| MousePheno | abnormal hindbrain morphology | 9.87e-04 | 485 | 23 | 5 | MP:0000841 | |
| MousePheno | abnormal pulmonary acinus morphology | 1.09e-03 | 284 | 23 | 4 | MP:0010911 | |
| MousePheno | abnormal thyroid gland physiology | 1.10e-03 | 30 | 23 | 2 | MP:0002876 | |
| Domain | - | 1.96e-03 | 663 | 26 | 5 | 2.60.40.10 | |
| Domain | ig | 2.27e-03 | 190 | 26 | 3 | PF00047 | |
| Domain | Immunoglobulin | 2.27e-03 | 190 | 26 | 3 | IPR013151 | |
| Domain | p53-like_TF_DNA-bd | 2.46e-03 | 53 | 26 | 2 | IPR008967 | |
| Domain | Ig-like_fold | 2.58e-03 | 706 | 26 | 5 | IPR013783 | |
| Domain | - | 1.00e-02 | 109 | 26 | 2 | 4.10.280.10 | |
| Domain | HLH | 1.04e-02 | 111 | 26 | 2 | PF00010 | |
| Domain | HLH | 1.13e-02 | 116 | 26 | 2 | SM00353 | |
| Domain | BHLH | 1.15e-02 | 117 | 26 | 2 | PS50888 | |
| Domain | bHLH_dom | 1.17e-02 | 118 | 26 | 2 | IPR011598 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.90e-05 | 110 | 21 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.50e-05 | 118 | 21 | 4 | M27316 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 6.36e-05 | 53 | 21 | 3 | M8276 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 8.26e-05 | 1387 | 21 | 9 | M734 | |
| Pathway | KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION | 1.15e-04 | 11 | 21 | 2 | M47438 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.34e-04 | 82 | 21 | 3 | MM15922 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 2.51e-04 | 84 | 21 | 3 | M1008 | |
| Pathway | KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION | 2.88e-04 | 88 | 21 | 3 | M16004 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 3.96e-04 | 98 | 21 | 3 | M48247 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.80e-04 | 22 | 21 | 2 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.72e-04 | 24 | 21 | 2 | M13404 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 6.73e-04 | 1432 | 21 | 8 | M509 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 6.98e-04 | 119 | 21 | 3 | M48309 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 7.15e-04 | 120 | 21 | 3 | M48233 | |
| Pathway | REACTOME_CARDIOGENESIS | 7.25e-04 | 27 | 21 | 2 | M48011 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.81e-04 | 28 | 21 | 2 | M6177 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 8.97e-04 | 30 | 21 | 2 | M39580 | |
| Pathway | WP_DOPAMINERGIC_NEUROGENESIS | 8.97e-04 | 30 | 21 | 2 | MM15831 | |
| Pathway | KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY | 1.05e-03 | 137 | 21 | 3 | M5669 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.36e-03 | 37 | 21 | 2 | M39506 | |
| Pathway | WP_RETT_SYNDROME | 2.29e-03 | 48 | 21 | 2 | M39759 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 2.29e-03 | 48 | 21 | 2 | MM14987 | |
| Pathway | REACTOME_HEME_SIGNALING | 2.38e-03 | 49 | 21 | 2 | M41832 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 2.68e-03 | 52 | 21 | 2 | M2404 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.89e-03 | 54 | 21 | 2 | MM14871 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 2.99e-03 | 55 | 21 | 2 | M27145 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 3.21e-03 | 57 | 21 | 2 | M48326 | |
| Pathway | PID_NOTCH_PATHWAY | 3.44e-03 | 59 | 21 | 2 | M17 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 3.55e-03 | 60 | 21 | 2 | M41830 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.67e-03 | 61 | 21 | 2 | M39540 | |
| Pathway | PID_ERA_GENOMIC_PATHWAY | 4.03e-03 | 64 | 21 | 2 | M200 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 4.15e-03 | 65 | 21 | 2 | M39682 | |
| Pubmed | CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression. | 2.06e-09 | 163 | 26 | 6 | 23333304 | |
| Pubmed | 3.11e-08 | 9 | 26 | 3 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 3.11e-08 | 9 | 26 | 3 | 8662091 | |
| Pubmed | 8.12e-08 | 12 | 26 | 3 | 20137308 | ||
| Pubmed | 1.34e-07 | 14 | 26 | 3 | 19875891 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 1.34e-07 | 14 | 26 | 3 | 15896204 | |
| Pubmed | 1.34e-07 | 14 | 26 | 3 | 19489269 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 20082646 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 19926642 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 20356536 | ||
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 20643584 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 1.68e-07 | 15 | 26 | 3 | 17498266 | |
| Pubmed | 1.68e-07 | 15 | 26 | 3 | 19326408 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 19897003 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 19000141 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 20670355 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 2.06e-07 | 16 | 26 | 3 | 19527230 | |
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 20652381 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 18668235 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 19279038 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 17868255 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 18643961 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 19309280 | ||
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 20331834 | ||
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 2.06e-07 | 16 | 26 | 3 | 16403292 | |
| Pubmed | 2.06e-07 | 16 | 26 | 3 | 20210919 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 19032228 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 20173784 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 20173792 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 20483367 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 19968064 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 2.50e-07 | 17 | 26 | 3 | 19218127 | |
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 2.50e-07 | 17 | 26 | 3 | 20878400 | |
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 20650299 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 19450876 | ||
| Pubmed | 2.50e-07 | 17 | 26 | 3 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 3.00e-07 | 18 | 26 | 3 | 19630074 | |
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 20519398 | ||
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 20200544 | ||
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 3.00e-07 | 18 | 26 | 3 | 19046302 | |
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 19846535 | ||
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 20580654 | ||
| Pubmed | 3.00e-07 | 18 | 26 | 3 | 20210918 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 3.57e-07 | 19 | 26 | 3 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 3.57e-07 | 19 | 26 | 3 | 18778326 | |
| Pubmed | 3.57e-07 | 19 | 26 | 3 | 20600442 | ||
| Pubmed | 3.57e-07 | 19 | 26 | 3 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 4.19e-07 | 20 | 26 | 3 | 20193031 | |
| Pubmed | 4.19e-07 | 20 | 26 | 3 | 20426625 | ||
| Pubmed | 4.19e-07 | 20 | 26 | 3 | 11877444 | ||
| Pubmed | 4.89e-07 | 21 | 26 | 3 | 19861144 | ||
| Pubmed | 5.66e-07 | 22 | 26 | 3 | 20492596 | ||
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 1.34e-06 | 29 | 26 | 3 | 20082482 | |
| Pubmed | Genetics of rheumatoid arthritis contributes to biology and drug discovery. | 1.44e-06 | 112 | 26 | 4 | 24390342 | |
| Pubmed | Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ. | 1.61e-06 | 3 | 26 | 2 | 30575522 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 33933467 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20667911 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 8765026 | ||
| Pubmed | Killer cell immunoglobulin-like receptor allele discrimination by high-resolution melting. | 1.61e-06 | 3 | 26 | 2 | 19589363 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 35916453 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 25957400 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 28993188 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 16239257 | ||
| Pubmed | 2.39e-06 | 35 | 26 | 3 | 19683555 | ||
| Pubmed | Automated yeast two-hybrid screening for nuclear receptor-interacting proteins. | 2.86e-06 | 133 | 26 | 4 | 15604093 | |
| Pubmed | Mammalian twisted gastrulation is essential for skeleto-lymphogenesis. | 3.22e-06 | 4 | 26 | 2 | 12665593 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 18952841 | ||
| Pubmed | HDAC3 is a critical negative regulator of long-term memory formation. | 3.22e-06 | 4 | 26 | 2 | 21228185 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 10770935 | ||
| Pubmed | Stimulation of NeuroD activity by huntingtin and huntingtin-associated proteins HAP1 and MLK2. | 3.22e-06 | 4 | 26 | 2 | 12881483 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.44e-06 | 908 | 26 | 7 | 19274049 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 19410616 | ||
| Pubmed | Integrated analysis of DNA methylation and RNA‑sequencing data in Down syndrome. | 5.37e-06 | 5 | 26 | 2 | 27667480 | |
| Pubmed | The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells. | 5.37e-06 | 5 | 26 | 2 | 21468021 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 10753860 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 15076712 | ||
| Pubmed | Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. | 5.37e-06 | 5 | 26 | 2 | 18388149 | |
| Pubmed | Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. | 5.37e-06 | 5 | 26 | 2 | 10882117 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 17132730 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 17468099 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 15728845 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19926752 | ||
| Pubmed | Amino acids important for ligand specificity of the human constitutive androstane receptor. | 8.05e-06 | 6 | 26 | 2 | 15572376 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19858347 | ||
| Pubmed | Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes. | 8.05e-06 | 6 | 26 | 2 | 20560679 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 12460926 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 12089346 | ||
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 14607943 | ||
| Pubmed | Loss of Notch2 and Notch3 in vascular smooth muscle causes patent ductus arteriosus. | 1.13e-05 | 7 | 26 | 2 | 26453897 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 12618911 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 1.13e-05 | 7 | 26 | 2 | 15748957 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 26928464 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 10531362 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 28574994 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 15730517 | ||
| Pubmed | A molecular roadmap of the AGM region reveals BMPER as a novel regulator of HSC maturation. | 1.50e-05 | 8 | 26 | 2 | 29093060 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 19786558 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 9430221 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 18681957 | ||
| Pubmed | 1.64e-05 | 66 | 26 | 3 | 23275444 | ||
| Interaction | CREBBP interactions | NCOR1 PLAGL1 REL KIF5A NEUROD1 RUNX1 KDM6B MAP1B SMAD1 ARNT2 | 1.73e-09 | 599 | 26 | 10 | int:CREBBP |
| Interaction | SIN3A interactions | 7.23e-06 | 380 | 26 | 6 | int:SIN3A | |
| Interaction | SMAD1 interactions | 1.31e-05 | 243 | 26 | 5 | int:SMAD1 | |
| Interaction | MED16 interactions | 1.61e-05 | 120 | 26 | 4 | int:MED16 | |
| Interaction | MED4 interactions | 1.89e-05 | 450 | 26 | 6 | int:MED4 | |
| Interaction | VDR interactions | 2.02e-05 | 127 | 26 | 4 | int:VDR | |
| Interaction | RUNX1T1 interactions | 2.02e-05 | 127 | 26 | 4 | int:RUNX1T1 | |
| Interaction | SMARCA4 interactions | 2.19e-05 | 462 | 26 | 6 | int:SMARCA4 | |
| Interaction | CCND1 interactions | 2.86e-05 | 286 | 26 | 5 | int:CCND1 | |
| Interaction | GTF2B interactions | 3.05e-05 | 141 | 26 | 4 | int:GTF2B | |
| Interaction | NR1I3 interactions | 3.17e-05 | 48 | 26 | 3 | int:NR1I3 | |
| Interaction | YAP1 interactions | 4.80e-05 | 1095 | 26 | 8 | int:YAP1 | |
| Interaction | RUNX1 interactions | 5.19e-05 | 324 | 26 | 5 | int:RUNX1 | |
| Interaction | MYOD1 interactions | 1.05e-04 | 194 | 26 | 4 | int:MYOD1 | |
| Interaction | MED17 interactions | 1.23e-04 | 202 | 26 | 4 | int:MED17 | |
| Interaction | PPARGC1A interactions | 1.58e-04 | 82 | 26 | 3 | int:PPARGC1A | |
| Interaction | MED22 interactions | 1.76e-04 | 85 | 26 | 3 | int:MED22 | |
| Interaction | WWTR1 interactions | 1.80e-04 | 422 | 26 | 5 | int:WWTR1 | |
| Interaction | POLR2H interactions | 1.80e-04 | 223 | 26 | 4 | int:POLR2H | |
| Interaction | AR interactions | 1.98e-04 | 992 | 26 | 7 | int:AR | |
| Interaction | MED25 interactions | 2.29e-04 | 93 | 26 | 3 | int:MED25 | |
| Interaction | SMAD3 interactions | 2.35e-04 | 447 | 26 | 5 | int:SMAD3 | |
| Interaction | EP300 interactions | 2.69e-04 | 1401 | 26 | 8 | int:EP300 | |
| Interaction | MED6 interactions | 2.92e-04 | 101 | 26 | 3 | int:MED6 | |
| Interaction | ARNT2 interactions | 3.01e-04 | 102 | 26 | 3 | int:ARNT2 | |
| Interaction | MED19 interactions | 3.37e-04 | 106 | 26 | 3 | int:MED19 | |
| Interaction | MED26 interactions | 3.46e-04 | 107 | 26 | 3 | int:MED26 | |
| Interaction | ASH2L interactions | 3.48e-04 | 265 | 26 | 4 | int:ASH2L | |
| Interaction | MED9 interactions | 3.56e-04 | 108 | 26 | 3 | int:MED9 | |
| Interaction | ZNF341 interactions | 3.64e-04 | 22 | 26 | 2 | int:ZNF341 | |
| Interaction | BACH1 interactions | 3.86e-04 | 111 | 26 | 3 | int:BACH1 | |
| Interaction | THRA interactions | 3.86e-04 | 111 | 26 | 3 | int:THRA | |
| Interaction | ZNF765 interactions | 4.34e-04 | 24 | 26 | 2 | int:ZNF765 | |
| Interaction | NR6A1 interactions | 4.34e-04 | 24 | 26 | 2 | int:NR6A1 | |
| Interaction | TSPOAP1 interactions | 4.71e-04 | 25 | 26 | 2 | int:TSPOAP1 | |
| Interaction | NR4A2 interactions | 5.51e-04 | 27 | 26 | 2 | int:NR4A2 | |
| Interaction | MED24 interactions | 5.85e-04 | 128 | 26 | 3 | int:MED24 | |
| Interaction | PPARG interactions | 6.06e-04 | 307 | 26 | 4 | int:PPARG | |
| Interaction | MED15 interactions | 6.26e-04 | 131 | 26 | 3 | int:MED15 | |
| Cytoband | 19q13.4 | 1.24e-05 | 79 | 26 | 3 | 19q13.4 | |
| Cytoband | 17p11.2 | 3.67e-03 | 159 | 26 | 2 | 17p11.2 | |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 1.26e-06 | 18 | 22 | 3 | 620 | |
| GeneFamily | Cyclins|Mediator complex | 7.29e-04 | 33 | 22 | 2 | 1061 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.32e-03 | 181 | 22 | 3 | 694 | |
| GeneFamily | Basic helix-loop-helix proteins | 7.83e-03 | 110 | 22 | 2 | 420 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 1.89e-06 | 212 | 26 | 5 | MM3816 | |
| Coexpression | CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN | 1.85e-05 | 52 | 26 | 3 | M12895 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | 1.89e-05 | 1250 | 26 | 8 | M41099 | |
| Coexpression | RAMASWAMY_METASTASIS_DN | 2.71e-05 | 59 | 26 | 3 | M16963 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN | 3.37e-05 | 648 | 26 | 6 | M14371 | |
| Coexpression | GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 4.31e-05 | 200 | 26 | 4 | M6200 | |
| Coexpression | GSE7852_TREG_VS_TCONV_THYMUS_UP | 4.31e-05 | 200 | 26 | 4 | M5730 | |
| Coexpression | BUSSLINGER_GASTRIC_G_CELLS | 1.24e-04 | 98 | 26 | 3 | M40018 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 3.33e-04 | 137 | 26 | 3 | M4781 | |
| Coexpression | BUSSLINGER_GASTRIC_D_CELLS | 3.52e-04 | 28 | 26 | 2 | M40017 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 3.85e-04 | 144 | 26 | 3 | M5942 | |
| Coexpression | TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL | 4.01e-04 | 146 | 26 | 3 | M41677 | |
| Coexpression | GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP | 4.25e-04 | 149 | 26 | 3 | M8786 | |
| Coexpression | BUSSLINGER_DUODENAL_EC_CELLS | 4.32e-04 | 31 | 26 | 2 | M40037 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 4.34e-04 | 150 | 26 | 3 | M8796 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 5.33e-04 | 161 | 26 | 3 | M40214 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS | 5.52e-04 | 35 | 26 | 2 | M39296 | |
| Coexpression | PHONG_TNF_RESPONSE_VIA_P38_PARTIAL | 5.63e-04 | 164 | 26 | 3 | M2502 | |
| Coexpression | MORI_PLASMA_CELL_DN | 5.84e-04 | 36 | 26 | 2 | M19509 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 5.84e-04 | 36 | 26 | 2 | M4389 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_12HR | 5.84e-04 | 36 | 26 | 2 | MM513 | |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP | 6.24e-04 | 170 | 26 | 3 | M6697 | |
| Coexpression | NAGASHIMA_NRG1_SIGNALING_UP | 6.46e-04 | 172 | 26 | 3 | M11585 | |
| Coexpression | MORI_PLASMA_CELL_DN | 6.51e-04 | 38 | 26 | 2 | MM598 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D2 | 6.51e-04 | 38 | 26 | 2 | M12861 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_6HR | 6.51e-04 | 38 | 26 | 2 | MM512 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION_6HR | 6.51e-04 | 38 | 26 | 2 | M1854 | |
| Coexpression | AIZARANI_LIVER_C25_KUPFFER_CELLS_4 | 6.68e-04 | 174 | 26 | 3 | M39126 | |
| Coexpression | CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP | 6.68e-04 | 174 | 26 | 3 | M2038 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | 6.79e-04 | 175 | 26 | 3 | M6723 | |
| Coexpression | JIANG_MELANOMA_TRM1_CD8 | 7.02e-04 | 177 | 26 | 3 | M48965 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP | 7.49e-04 | 181 | 26 | 3 | M8579 | |
| Coexpression | HAHTOLA_SEZARY_SYNDROM_DN | 8.33e-04 | 43 | 26 | 2 | M18968 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP | 8.49e-04 | 189 | 26 | 3 | M4199 | |
| Coexpression | EGFR_UP.V1_UP | 8.89e-04 | 192 | 26 | 3 | M2634 | |
| Coexpression | GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP | 9.02e-04 | 193 | 26 | 3 | M4177 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN | 9.12e-04 | 45 | 26 | 2 | M10084 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP | 9.29e-04 | 195 | 26 | 3 | M4195 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 9.43e-04 | 196 | 26 | 3 | M3243 | |
| Coexpression | GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN | 9.57e-04 | 197 | 26 | 3 | M3110 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | 9.66e-04 | 452 | 26 | 4 | M18685 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP | 9.71e-04 | 198 | 26 | 3 | M4295 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN | 9.71e-04 | 198 | 26 | 3 | M7716 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN | 9.85e-04 | 199 | 26 | 3 | M9031 | |
| Coexpression | GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN | 9.85e-04 | 199 | 26 | 3 | M7260 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 9.85e-04 | 199 | 26 | 3 | M6264 | |
| Coexpression | GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP | 9.85e-04 | 199 | 26 | 3 | M3262 | |
| Coexpression | GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP | 9.85e-04 | 199 | 26 | 3 | M8396 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 9.85e-04 | 199 | 26 | 3 | M8381 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP | 9.85e-04 | 199 | 26 | 3 | M9745 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN | 9.85e-04 | 199 | 26 | 3 | M4328 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN | 1.00e-03 | 200 | 26 | 3 | M8032 | |
| Coexpression | GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN | 1.00e-03 | 200 | 26 | 3 | M8076 | |
| Coexpression | GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN | 1.00e-03 | 200 | 26 | 3 | M5834 | |
| Coexpression | GSE27786_NKCELL_VS_NKTCELL_UP | 1.00e-03 | 200 | 26 | 3 | M4851 | |
| Coexpression | GSE15330_WT_VS_IKAROS_KO_HSC_UP | 1.00e-03 | 200 | 26 | 3 | M7040 | |
| Coexpression | HALLMARK_TNFA_SIGNALING_VIA_NFKB | 1.00e-03 | 200 | 26 | 3 | M5890 | |
| Coexpression | GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP | 1.00e-03 | 200 | 26 | 3 | M9742 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP | 1.00e-03 | 200 | 26 | 3 | M4456 | |
| Coexpression | GSE7460_TCONV_VS_TREG_THYMUS_DN | 1.00e-03 | 200 | 26 | 3 | M5676 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP | 1.00e-03 | 200 | 26 | 3 | M8705 | |
| Coexpression | FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP | 1.04e-03 | 48 | 26 | 2 | M7202 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.08e-03 | 49 | 26 | 2 | M17173 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.09e-03 | 467 | 26 | 4 | M1347 | |
| Coexpression | DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS | 1.13e-03 | 50 | 26 | 2 | M40296 | |
| Coexpression | MCCLUNG_DELTA_FOSB_TARGETS_8WK | 1.17e-03 | 51 | 26 | 2 | MM647 | |
| Coexpression | DESCARTES_FETAL_LUNG_VISCERAL_NEURONS | 1.18e-03 | 212 | 26 | 3 | M40249 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.24e-03 | 484 | 26 | 4 | MM999 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 1.27e-03 | 843 | 26 | 5 | M2356 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.33e-03 | 493 | 26 | 4 | M19391 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 1.36e-03 | 856 | 26 | 5 | M4500 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.41e-03 | 56 | 26 | 2 | M3576 | |
| Coexpression | NAGASHIMA_EGF_SIGNALING_UP | 1.46e-03 | 57 | 26 | 2 | M16311 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.20e-09 | 385 | 24 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 8.18e-09 | 818 | 24 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.73e-06 | 369 | 24 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 7.42e-06 | 34 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 2.22e-05 | 149 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_200 | 3.63e-05 | 169 | 24 | 4 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 3.93e-05 | 884 | 24 | 7 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 4.20e-05 | 893 | 24 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#2_top-relative-expression-ranked_200 | 5.80e-05 | 67 | 24 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 6.06e-05 | 68 | 24 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 6.22e-05 | 194 | 24 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 7.14e-05 | 201 | 24 | 4 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 8.30e-05 | 209 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_200 | 9.13e-05 | 78 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | 9.32e-05 | 421 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 9.42e-05 | 422 | 24 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_100 | 1.10e-04 | 83 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500 | 1.22e-04 | 231 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#4_top-relative-expression-ranked_500 | 1.49e-04 | 92 | 24 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.97e-04 | 101 | 24 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | 1.98e-04 | 791 | 24 | 6 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 2.07e-04 | 19 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | 2.20e-04 | 806 | 24 | 6 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_100 | 2.30e-04 | 20 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | 2.38e-04 | 818 | 24 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 2.69e-04 | 837 | 24 | 6 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#5_top-relative-expression-ranked_500 | 3.33e-04 | 24 | 24 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_500_k5 | |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_500_k-means-cluster#2 | 3.60e-04 | 124 | 24 | 3 | ratio_ECTO_vs_SC_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.85e-04 | 312 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.19e-04 | 319 | 24 | 4 | ratio_DE_vs_SC_1000_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.76e-04 | 330 | 24 | 4 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.39e-04 | 151 | 24 | 3 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k4 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_top-relative-expression-ranked_1000 | 6.75e-04 | 646 | 24 | 5 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 6.90e-04 | 155 | 24 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#1_top-relative-expression-ranked_100 | 7.53e-04 | 36 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k1_100 | |
| CoexpressionAtlas | cerebral cortex | 7.68e-04 | 1428 | 24 | 7 | cerebral cortex | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_100 | 8.40e-04 | 38 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_200 | 9.17e-04 | 171 | 24 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.51e-04 | 397 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 9.96e-04 | 402 | 24 | 4 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_top-relative-expression-ranked_200 | 9.97e-04 | 176 | 24 | 3 | gudmap_dev gonad_e11.5_M_GonMes_Sma_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.03e-03 | 178 | 24 | 3 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k5_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 1.04e-03 | 407 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500 | 1.05e-03 | 408 | 24 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.10e-03 | 413 | 24 | 4 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 1.11e-03 | 414 | 24 | 4 | GSM854271_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 1.13e-03 | 416 | 24 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 1.14e-03 | 417 | 24 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_100 | 1.28e-03 | 47 | 24 | 2 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_100_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | 1.30e-03 | 432 | 24 | 4 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.52e-03 | 204 | 24 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 1.63e-03 | 53 | 24 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.69e-03 | 54 | 24 | 2 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_k2_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 1.71e-03 | 795 | 24 | 5 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 1.81e-03 | 806 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | 1.86e-03 | 811 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#4_top-relative-expression-ranked_500 | 1.95e-03 | 58 | 24 | 2 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.02e-03 | 225 | 24 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | 2.02e-03 | 826 | 24 | 5 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.04e-03 | 226 | 24 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 2.06e-03 | 490 | 24 | 4 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#1_top-relative-expression-ranked_200 | 2.15e-03 | 61 | 24 | 2 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k1_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_500 | 2.15e-03 | 61 | 24 | 2 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | 2.25e-03 | 847 | 24 | 5 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder detrusor (LCM)_emap-30376_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.29e-03 | 63 | 24 | 2 | gudmap_developingLowerUrinaryTract_P2_bladder detrusor (LCM)_1000_k3 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.31e-03 | 236 | 24 | 3 | gudmap_kidney_P3_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | 2.38e-03 | 858 | 24 | 5 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 2.51e-03 | 66 | 24 | 2 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | 2.66e-03 | 880 | 24 | 5 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-08 | 188 | 25 | 5 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-08 | 191 | 25 | 5 | a251b134f67a0a1ef3a42f50042f128a17f20b22 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-08 | 192 | 25 | 5 | 1304e69c92cef3bd8c82e3c035a7562f5440139a | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.01e-08 | 194 | 25 | 5 | 92b39a935e8c577eb1123d706d168fa13cf3344c | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 2.13e-06 | 166 | 25 | 4 | d638d356592325cded4a6cb549041cf2f8d3e62c | |
| ToppCell | facs-Pancreas-Endocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-06 | 189 | 25 | 4 | 010fdd70e9d0e21b856306a29ff877776a480319 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-06 | 191 | 25 | 4 | fd01a206763dfb6d52cca67123571936b4a8e1a0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 192 | 25 | 4 | c47df468cf78a90929913c9022e8078a53cdf680 | |
| ToppCell | droplet-Pancreas-Endocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 192 | 25 | 4 | 4510aa262da8dcf7c944b3907a51aba5a9397a4e | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 192 | 25 | 4 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | tumor_Lung|World / Location, Cell class and cell subclass | 3.95e-06 | 194 | 25 | 4 | 7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-06 | 194 | 25 | 4 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 195 | 25 | 4 | f41a68b7c2621594db8d8952e301eeadc96be26f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 195 | 25 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-06 | 195 | 25 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-06 | 196 | 25 | 4 | eea354bdaf4c558df6a94ec4f2f817f7073821d9 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.37e-06 | 199 | 25 | 4 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.37e-06 | 199 | 25 | 4 | 86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.46e-06 | 200 | 25 | 4 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.46e-06 | 200 | 25 | 4 | 48ca9269ee3962d13408fef12b5be120759eac52 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.46e-06 | 200 | 25 | 4 | cbd0b9188a94778ffa539912aeb2a4378f0ab88f | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.79e-05 | 135 | 25 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.89e-05 | 156 | 25 | 3 | 0f54d62c0fc08bbdd5ac743b2d5d748c3d1e6ef9 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-05 | 159 | 25 | 3 | af137688e06a97ff97bb7def54f0dd164d155b11 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8+/CD4+_Mixed_Th|normal_Lymph_Node / Location, Cell class and cell subclass | 9.94e-05 | 162 | 25 | 3 | 12bd0b99aee13da60d0684a5e2a705824db1899c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 163 | 25 | 3 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 1.11e-04 | 168 | 25 | 3 | ea465152ea31391b63c02425beafa9a4f51f6703 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 169 | 25 | 3 | b66ffc2b2b6bfcc3a6e639d9d31d3de95f4a94e1 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D3|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 170 | 25 | 3 | 7a8b90ff37c5b3b31820924a3e7f4ce20319f896 | |
| ToppCell | facs|World / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 25 | 3 | c9990bc041a632b2f7bbebbfe737772c423d7027 | |
| ToppCell | COVID-19-Myeloid-MoAM5,_CCL3L1|COVID-19 / Condition, Lineage and Cell class | 1.21e-04 | 173 | 25 | 3 | 502f888b7684ed39f5c577eedcacf673ae81d39e | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 174 | 25 | 3 | 742c73c9e090848b464323cb17579b86658c6792 | |
| ToppCell | E18.5-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 174 | 25 | 3 | 7fed9722e64c60843092f2ba71256e3043011ef6 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-04 | 175 | 25 | 3 | bb898796662b97f7459b7dda7cecf6a9bde8b055 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-04 | 176 | 25 | 3 | a31d7532f8c055d4e62bbaa78d819f2495bfee00 | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 176 | 25 | 3 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 1.31e-04 | 178 | 25 | 3 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 179 | 25 | 3 | d96741c5c551e36421b2ad938072ab7d506c3835 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.34e-04 | 179 | 25 | 3 | af0b54c9ea0b6e4210f22dbb6e88ecd3276a5f86 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | 9db9899ca42455310e9b63df523fe6c4780abfb7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 180 | 25 | 3 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.36e-04 | 180 | 25 | 3 | cf7d8bf9eee2dfab2c8a6780e296b05ad42041bf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 180 | 25 | 3 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | (1)_B_cells-(1)_B_CD27pos|(1)_B_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.38e-04 | 181 | 25 | 3 | d2476956ca13f9234d7e77c3ee432dd54eebeac4 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 181 | 25 | 3 | d66838fca0429cad2079cd8d92a5cd33eb0d3522 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-04 | 181 | 25 | 3 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | facs-BAT-Fat-18m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 182 | 25 | 3 | efc335f4e566533cfbcd17262bd94ae64fa2e117 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-04 | 182 | 25 | 3 | 5f1f10c845b73d1f69794277925ef847ff23ac2d | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 1.40e-04 | 182 | 25 | 3 | 0ef8fb13488a65717b050b1b4e4bf062a1553eff | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-04 | 182 | 25 | 3 | 209b455eaa135825fa6e6c71bf7d2072cebf11f2 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 182 | 25 | 3 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.43e-04 | 183 | 25 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 25 | 3 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 183 | 25 | 3 | 7534587fa35837c0aaca93c542f2eee493eba637 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 184 | 25 | 3 | b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 184 | 25 | 3 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-04 | 184 | 25 | 3 | abb61e744a9031e0c91eb560a8f486a0ca5a01cc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-04 | 185 | 25 | 3 | 0382bfbc96c23403b18fe439d8070ea9a7d29fd2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-04 | 185 | 25 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-04 | 186 | 25 | 3 | 24b23880d4ff8fb4a23e2012d5890b9e2fcf7283 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 186 | 25 | 3 | 1a1e5d85a5ad90afee234c12a9b54a5e93a8a2f2 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 186 | 25 | 3 | f1366638edaecad5cad6367440f4c693513bed7e | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_postreplicative|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 186 | 25 | 3 | cf96f880e6e22189593ce1357c55e65c34644559 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.50e-04 | 186 | 25 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 187 | 25 | 3 | a748b3a59e398e0da019db3f16d38adb1960c29f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 187 | 25 | 3 | b426a67b5669019115b58295ce7d304beeb75825 | |
| ToppCell | droplet-Pancreas|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 5f4df092452d8672bda4059c794e099ba3f5a8fa | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.52e-04 | 187 | 25 | 3 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 187 | 25 | 3 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 188 | 25 | 3 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.54e-04 | 188 | 25 | 3 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | B_cells-Naive_B_cells_|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.54e-04 | 188 | 25 | 3 | d1bc1316bbb8cfc39acc70f8680b14d19f536997 | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.54e-04 | 188 | 25 | 3 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Cytotoxic_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.54e-04 | 188 | 25 | 3 | c80956649b10b7dd7540394a00fc2a0619b27e80 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 188 | 25 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 188 | 25 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 188 | 25 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-04 | 189 | 25 | 3 | 0fe8901e10c619c93b7788792da1706a32102c6e | |
| ToppCell | facs-Limb_Muscle|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 189 | 25 | 3 | 21ec43859d21ffc565acbe36489da1d2d0f9877d | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 1.57e-04 | 189 | 25 | 3 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.57e-04 | 189 | 25 | 3 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A4_(IN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 189 | 25 | 3 | cceca3d14dd559bbb2cb4b81ea12c2b62d18ee49 | |
| ToppCell | COPD-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.57e-04 | 189 | 25 | 3 | c0ac160fa7e68b92414fb1600abcac8ad1a42232 | |
| ToppCell | RA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 1.57e-04 | 189 | 25 | 3 | b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 189 | 25 | 3 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.59e-04 | 190 | 25 | 3 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 190 | 25 | 3 | bdbfaced785db79ff965f332759be258dbf743cf | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 190 | 25 | 3 | 92456f6f7eced6e4c4371f495254a65d061c8d0b | |
| ToppCell | Severe-B_activate-7|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.59e-04 | 190 | 25 | 3 | 67e6c8a5a8724bdf2861fd76a711319dfc71d47a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | ILEUM|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.59e-04 | 190 | 25 | 3 | 4395dbd18c14d491f5066a2ddac438a16b1fd7c3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 190 | 25 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 190 | 25 | 3 | 600b9674197f743dea1d19d3df0fc993b6e6aa25 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.59e-04 | 190 | 25 | 3 | 4d401b73c0e7eb38e95d0851a128bf12bb0d3a9f | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-04 | 190 | 25 | 3 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 191 | 25 | 3 | 9032aa974aa1b7b1095b8d1b58dcb087358a5001 | |
| ToppCell | IPF-Lymphoid-NK|Lymphoid / Disease state, Lineage and Cell class | 1.62e-04 | 191 | 25 | 3 | f2ddc0962007d7a4e78fbd916ebb62fc557d480a | |
| Computational | Intracellular transport (MT cytoskeleton and motors). | 6.09e-04 | 21 | 19 | 2 | MODULE_253 | |
| Computational | Genes in the cancer module 196. | 7.33e-04 | 23 | 19 | 2 | MODULE_196 | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; PC3; HT_HG-U133A | 7.52e-08 | 196 | 26 | 6 | 4673_UP | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; HL60; HT_HG-U133A | 9.11e-07 | 159 | 26 | 5 | 2192_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 1.42e-06 | 174 | 26 | 5 | 1302_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; MCF7; HT_HG-U133A | 2.75e-06 | 199 | 26 | 5 | 4700_DN | |
| Drug | Asbestos, Crocidolite | 5.54e-06 | 1241 | 26 | 9 | ctd:D017638 | |
| Drug | C-cluster | 1.79e-05 | 139 | 26 | 4 | CID000446537 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 2.08e-05 | 302 | 26 | 5 | ctd:D003633 | |
| Drug | Sp 1 (pharmaceutical) | 2.89e-05 | 548 | 26 | 6 | CID000099040 | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; HL60; HT_HG-U133A | 3.27e-05 | 162 | 26 | 4 | 1339_UP | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.94e-05 | 170 | 26 | 4 | 4680_UP | |
| Drug | Pyrvinium pamoate [3546-41-6]; Up 200; 3.4uM; HL60; HT_HG-U133A | 4.04e-05 | 171 | 26 | 4 | 2957_UP | |
| Drug | pararosaniline base; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 4.62e-05 | 177 | 26 | 4 | 893_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 5.96e-05 | 189 | 26 | 4 | 4450_UP | |
| Drug | Seneciphylline [480-81-9]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 4822_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 3404_UP | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; PC3; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 2114_UP | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 6.60e-05 | 194 | 26 | 4 | 6516_DN | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 5330_UP | |
| Drug | Folic acid [59-30-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 7201_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 7034_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 6.73e-05 | 195 | 26 | 4 | 3755_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 7541_DN | |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 4227_DN | |
| Drug | Lynestrenol [52-76-6]; Up 200; 14uM; PC3; HT_HG-U133A | 6.86e-05 | 196 | 26 | 4 | 6756_UP | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; HL60; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 3000_UP | |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 4758_UP | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 3413_UP | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; PC3; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 6636_UP | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; MCF7; HT_HG-U133A | 7.00e-05 | 197 | 26 | 4 | 5415_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4804_UP | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4655_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3356_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 3292_DN | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Up 200; 2.8uM; HL60; HG-U133A | 7.14e-05 | 198 | 26 | 4 | 1391_UP | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; HL60; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 2730_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 6501_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 7357_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 1523_UP | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 5492_UP | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4251_UP | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; PC3; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 6668_UP | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; PC3; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 4201_UP | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; PC3; HG-U133A | 7.28e-05 | 199 | 26 | 4 | 1936_UP | |
| Drug | 2-nitro-p-cresol | 8.79e-05 | 76 | 26 | 3 | CID000008391 | |
| Drug | D-Au | 9.14e-05 | 77 | 26 | 3 | CID000277822 | |
| Drug | Aa1 | 1.14e-04 | 83 | 26 | 3 | CID009549188 | |
| Drug | U285 | 2.49e-04 | 108 | 26 | 3 | CID000009475 | |
| Drug | debromoaplysiatoxin | 2.60e-04 | 21 | 26 | 2 | CID000002967 | |
| Drug | mobs | 2.86e-04 | 22 | 26 | 2 | CID003674064 | |
| Drug | AC1L1AQK | 3.32e-04 | 119 | 26 | 3 | CID000001105 | |
| Drug | Methoxychlor | 3.46e-04 | 549 | 26 | 5 | ctd:D008731 | |
| Drug | AC1L2E0P | 3.83e-04 | 307 | 26 | 4 | CID000019390 | |
| Drug | PeCDD | 4.32e-04 | 27 | 26 | 2 | CID000038439 | |
| Drug | AS605240 | 5.00e-04 | 29 | 26 | 2 | CID005289247 | |
| Drug | gp120 protein, Human immunodeficiency virus 1 | 5.35e-04 | 30 | 26 | 2 | ctd:C514793 | |
| Drug | Zlllal | 5.73e-04 | 613 | 26 | 5 | CID000107707 | |
| Drug | Mustard Gas | 5.91e-04 | 1341 | 26 | 7 | ctd:D009151 | |
| Drug | bunazosin | 6.09e-04 | 32 | 26 | 2 | CID000002472 | |
| Drug | pristane | 6.78e-04 | 152 | 26 | 3 | CID000015979 | |
| Drug | Astemizole [68844-77-9]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 6.78e-04 | 152 | 26 | 3 | 6807_UP | |
| Drug | Benzalkonium Compounds | 6.88e-04 | 34 | 26 | 2 | ctd:D001548 | |
| Drug | TCDF | 6.88e-04 | 34 | 26 | 2 | CID000039929 | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 7.44e-04 | 157 | 26 | 3 | 2651_UP | |
| Drug | 5a-(3-formylphenylsulfanyl)-dihydrobicyclomycin | 7.71e-04 | 36 | 26 | 2 | CID005288236 | |
| Drug | Azaguanine-8 [134-58-7]; Up 200; 26.2uM; HL60; HT_HG-U133A | 7.72e-04 | 159 | 26 | 3 | 1833_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A | 7.72e-04 | 159 | 26 | 3 | 4328_UP | |
| Drug | mono-(2-ethylhexyl)phthalate | 7.89e-04 | 658 | 26 | 5 | ctd:C016599 | |
| Drug | 2,4,4'-trichlorobiphenyl | 8.01e-04 | 1411 | 26 | 7 | ctd:C081766 | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.15e-04 | 162 | 26 | 3 | 5018_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A | 8.75e-04 | 166 | 26 | 3 | 5826_UP | |
| Drug | Strophanthidin [66-28-4]; Up 200; 9.8uM; HL60; HT_HG-U133A | 8.75e-04 | 166 | 26 | 3 | 2525_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A | 8.90e-04 | 167 | 26 | 3 | 6680_UP | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; HL60; HG-U133A | 8.90e-04 | 167 | 26 | 3 | 1745_UP | |
| Drug | MDPC | 9.05e-04 | 39 | 26 | 2 | CID000032842 | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | 9.07e-04 | 1441 | 26 | 7 | ctd:C009828 | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; HL60; HT_HG-U133A | 9.21e-04 | 169 | 26 | 3 | 2193_UP | |
| Drug | BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 9.21e-04 | 169 | 26 | 3 | 1132_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; PC3; HT_HG-U133A | 9.21e-04 | 169 | 26 | 3 | 6724_UP | |
| Drug | Suloctidil [54063-56-8]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.37e-04 | 170 | 26 | 3 | 5021_UP | |
| Drug | Digoxin [20830-75-5]; Up 200; 5.2uM; HL60; HT_HG-U133A | 9.37e-04 | 170 | 26 | 3 | 2423_UP | |
| Drug | calmidazolium chloride; Up 200; 5uM; MCF7; HT_HG-U133A_EA | 9.69e-04 | 172 | 26 | 3 | 906_UP | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 1.00e-03 | 174 | 26 | 3 | 2456_UP | |
| Drug | C15H20O3 | 1.02e-03 | 175 | 26 | 3 | CID000004692 | |
| Drug | daunorubicin HCl; Up 200; 1uM; MCF7; HT_HG-U133A | 1.04e-03 | 176 | 26 | 3 | 7525_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.04e-03 | 176 | 26 | 3 | 5291_UP | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.04e-03 | 176 | 26 | 3 | 6980_DN | |
| Drug | Digoxigenin [1672-46-4]; Up 200; 10.2uM; HL60; HT_HG-U133A | 1.05e-03 | 177 | 26 | 3 | 3060_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.05e-03 | 177 | 26 | 3 | 7324_UP | |
| Drug | ecdysone | 1.07e-03 | 178 | 26 | 3 | CID000019212 | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 5590_UP | |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 4452_UP | |
| Drug | Digitoxigenin [143-62-4]; Up 200; 10.6uM; PC3; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 4217_UP | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 2656_UP | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.09e-03 | 179 | 26 | 3 | 4585_DN | |
| Drug | AC1L1XLP | 1.10e-03 | 43 | 26 | 2 | CID000011554 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Up 200; 11.8uM; PC3; HT_HG-U133A | 1.11e-03 | 180 | 26 | 3 | 4652_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 180 | 26 | 3 | 1477_UP | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.11e-03 | 180 | 26 | 3 | 4641_UP | |
| Drug | Menadione [58-27-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 1.12e-03 | 181 | 26 | 3 | 4662_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; PC3; HT_HG-U133A | 1.14e-03 | 182 | 26 | 3 | 6663_UP | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.03e-05 | 6 | 25 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Glioblastoma | 4.07e-05 | 79 | 25 | 3 | C0017636 | |
| Disease | killer cell immunoglobulin-like receptor 2DL4 measurement | 4.52e-05 | 12 | 25 | 2 | EFO_0008197 | |
| Disease | Giant Cell Glioblastoma | 4.89e-05 | 84 | 25 | 3 | C0334588 | |
| Disease | Glioblastoma Multiforme | 1.12e-04 | 111 | 25 | 3 | C1621958 | |
| Disease | Endometrioma | 3.36e-04 | 161 | 25 | 3 | C0269102 | |
| Disease | Endometriosis | 3.36e-04 | 161 | 25 | 3 | C0014175 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 3.37e-04 | 32 | 25 | 2 | DOID:332 (is_implicated_in) | |
| Disease | Rheumatoid Arthritis | 4.21e-04 | 174 | 25 | 3 | C0003873 | |
| Disease | Intellectual Disability | 5.11e-04 | 447 | 25 | 4 | C3714756 | |
| Disease | Breast adenocarcinoma | 5.54e-04 | 41 | 25 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.54e-04 | 41 | 25 | 2 | C0496956 | |
| Disease | testosterone measurement | 5.61e-04 | 1275 | 25 | 6 | EFO_0004908 | |
| Disease | refractive error, age at onset, Myopia | 5.70e-04 | 193 | 25 | 3 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | eye colour measurement | 8.11e-04 | 218 | 25 | 3 | EFO_0009764 | |
| Disease | eosinophil percentage of granulocytes | 9.95e-04 | 234 | 25 | 3 | EFO_0007996 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 1.22e-03 | 61 | 25 | 2 | C1961102 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 1.30e-03 | 63 | 25 | 2 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | QRS duration | 1.99e-03 | 298 | 25 | 3 | EFO_0005055 | |
| Disease | age of onset of asthma | 2.04e-03 | 79 | 25 | 2 | OBA_2001001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HSSSPYVVYPSDKPF | 31 | Q86XR8 | |
| GTSHTYPADPSSYSP | 601 | Q9HBZ2 | |
| YGSVPHSPYQLSAPS | 196 | P43630 | |
| GKYPTPPSQHSYASS | 2381 | Q04721 | |
| YGSVPHSPYQLSAPS | 101 | P43632 | |
| SVTGSAGHTPYYQSP | 1326 | P46821 | |
| SSSGHPSKPYYAPGA | 66 | O15054 | |
| YGSVPHSPYQFSAPS | 101 | Q14952 | |
| FYHFGSTSSSPPISP | 446 | Q8IZQ8 | |
| SGAYPLTSPPTSYHS | 1016 | O60244 | |
| NSHTAYYPPVTGPGD | 136 | Q53EP0 | |
| PPVSTGSATHYPYSV | 461 | P54257 | |
| HYPASSPTNPYGTRS | 926 | Q12840 | |
| PYHYPKAGSENPSIS | 341 | P42658 | |
| GSPSHSKSPAYTPQN | 1446 | Q15648 | |
| HSGSVYYKPSSPPTP | 116 | P43354 | |
| HYPGAFTYSPTPVTS | 321 | Q01196 | |
| PPLPNHKYNTTSTSY | 296 | Q9UM63 | |
| LYTSSAFPSGKPQPH | 1881 | O75376 | |
| PPHPLAYTSTTNFKG | 356 | B4DS77 | |
| SYPNSPGSSSSTYPH | 191 | Q15797 | |
| SKPPAYAYPATPSSH | 1016 | O15417 | |
| SYYPSPGPISSGLSH | 386 | Q04864 | |
| PASSKSSFGHPYTIP | 1566 | Q96AY4 | |
| HTYGQPYSHSPAPSA | 156 | Q562E7 | |
| SASFPVHPYSYQSPG | 211 | Q13562 |